Frontiers in Pharmacology | Respiratory Pharmacology

Original Research

Published on 30 Oct 2025

Therapeutic efficacy of deslanoside in oleic acid-induced acute lung injury in rabbits: Implications for clinical drug use and pharmacological strategies

in Respiratory Pharmacology

Rong Hu
Yi Zheng
Ning Li
Yong Pan
Xiaozhen Zhou
Lu Liu
Dizheng Liao
Yafei Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1683838

157 views

Review

Published on 29 Oct 2025

Medicinal plants and compounds for chronic bronchitis treatment: efficacy and action mechanisms

in Respiratory Pharmacology

Wei Ding
Danni Chen
Jiawang Li
Yan Wang
Xiangyun Chen
Yihe Xu
Zhen Yang
Zhenhong Liu
Hongxia Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1674079

326 views

Original Research

Published on 29 Oct 2025

Beyond Trikafta: new models to assess tissue dependent rescue of N1303K-CFTR

in Respiratory Pharmacology

Iwona Pranke
Valeria Capurro
Benoit Chevalier
Emanuela Pesce
Valeria Tomati
Cristina Pastorino
Mairead Kelly-Aubert
Aurelie Hatton
Elise Dreano
Mariateresa Lena

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1661417

807 views

Review

Accepted on 27 Oct 2025

Repolarization of inflammatory macrophages into reparative stage targeting cannabinoid receptor2: a potential perspective to dampen lung injury/ARDS

in Respiratory Pharmacology

Chloe Benedict
Jagdish Chandra Joshi

Frontiers in Pharmacology

Review

Published on 27 Oct 2025

The role of TGF-β1 in chronic multilobar segmental bronchial stenosis and advances in targeted drug research

in Respiratory Pharmacology

Mingjun Wu
Qian Yang
Youcheng Xie
Yan Hou
Qingliang Xue

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1649570

264 views

Original Research

Published on 24 Oct 2025

Montelukast: risk of mental disorders vs. efficacy–a meta-analysis

in Respiratory Pharmacology

Marharyta Sobczak
Rafał Pawliczak

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1659852

670 views

Review

Published on 23 Oct 2025

Diabetes mellitus-driven pulmonary injury: multidimensional mechanisms linking metabolic dysregulation to gut-lung axis and promising therapies

in Respiratory Pharmacology

Jiacheng Sun
Junyang Chen
Yuntian Shen
Xinlei Yao
Hualin Sun
Bingqian Chen
Jian Feng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1689522

643 views

Original Research

Accepted on 22 Oct 2025

Somatostatin receptors 3 and 5 potentiate cholinergic-nerve-mediated contraction in human bronchus

in Respiratory Pharmacology

Marion BROLLO
Stanislas Grassin-Delyle
Camille Roquencourt
Elisabeth Longchampt
Isabelle Miguet-Besson
Matthieu Glorion
Hélène Salvator
Philippe Devillier

Frontiers in Pharmacology

289 views

Case Report

Accepted on 21 Oct 2025

Telitacicept for Interstitial Lung Disease Associated With Idiopathic Inflammatory Myopathies: An Observational Study

in Respiratory Pharmacology

Xue Chen
Mengshan Li
Mingfang Sun
Xi Zhao
Yan Chen
Huanzi Dai

Frontiers in Pharmacology

358 views

Case Report

Published on 14 Oct 2025

Case Report: Botulism associated with cosmetic BoNT-A injections: respiratory failure and multidrug-resistant infection as emerging clinical challenges

in Respiratory Pharmacology

Yiming Song
Jinyu Li
Yujiao Ren
Wei Zhang
Hongbo Liu
Zhenyi Li
Jiarui Xu
Xingguo Zhang
Dongxing Liu
Yi Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1680693

604 views

Review

Accepted on 29 Sep 2025

Artemisinin and its derivatives: all-rounders that may prevent the progression from lung injury to lung cancer

in Respiratory Pharmacology

XIN XIE
Qian Chen
Cui Guo
Jinhao Zeng
Qingying He

Frontiers in Pharmacology

430 views

Original Research

Published on 26 Sep 2025

NHANES-based assessment of neutrophil-percentage-to-albumin and neutrophil-to-lymphocyte ratios as moderate predictors of mortality in adults with chronic respiratory diseases

in Respiratory Pharmacology

Feng Xu
Pan Jiang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1582120

1,666 views

Original Research

Published on 22 Sep 2025

The interaction between obesity and sex alters the response to house dust mite in an experimental model of allergic lung inflammation

in Respiratory Pharmacology

Amanda Santos-Cavalcante
Alembert Lino Alvarado
Vinicius Cooper Capetini
Julia Camargo Ricci
Gabriel Forato Anhê
Clive Peter Page
Yanira Riffo-Vasquez

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1672504

3,278 views

Original Research

Published on 09 Sep 2025

Liver X receptor agonist T0901317 alleviates sepsis-induced acute lung injury by enhancing macrophage autophagy

in Respiratory Pharmacology

Ben Wang
Ran Wang
Xueling Wu
Yu Zhong
Chaowang Huang
Zhi Xu
Liang Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1552034

2,831 views

Original Research

Published on 05 Sep 2025

Nasal cells as a bronchial cell surrogate for pre-clinical assessment of drug response in cystic fibrosis

in Respiratory Pharmacology

Malina Barillaro
Julie Avolio
Sharaniyaa Balachandran
Claire Bartlett
Wan Ip
Hong Ouyang
Wenming Duan
Joseph Zabner
Shaf Keshavjee
Christine Bear

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1651122

2,394 views

Original Research

Accepted on 04 Sep 2025

Lauric acid modulates the cyclooxygenases and nitric oxide pathways and reduces oxidative stress in preventing tracheal hyperresponsiveness in asthmatic Wistar rats

in Respiratory Pharmacology

Indyra Alencar Duarte Figueiredo
Alissa Maria De Oliveira Martins
Alexya Mikelle Teixeira Cavalcanti
Jayne Muniz Fernandes
Ludmila Emilly da Silva Gomes
Gabriel Nunes Machado de Oliveira
Lucas Nóbrega de Oliveira
Isabela Motta Felício
Adriana Maria Fernandes de Oliveira Golzio
Luiz Henrique César Vasconcelos

Frontiers in Pharmacology

2,741 views